Back to Search
Start Over
Bevacizumab plus chemotherapy (bev/CT) as first-line therapy for patients with potentially resectable metastatic colorectal cancer (mCRC): Final results of the French noninterventional PICASSO study
- Source :
- Journal of Clinical Oncology. 34:3554-3554
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 3554Background: Few prospective studies specifically focused on the management of potentially resectable patients with mCRC. This prospective non-interventional cohort evaluated patients (pts) with...
- Subjects :
- Oncology
Cancer Research
Chemotherapy
medicine.medical_specialty
Bevacizumab
Colorectal cancer
business.industry
medicine.medical_treatment
medicine.disease
digestive system diseases
03 medical and health sciences
0302 clinical medicine
First line therapy
030220 oncology & carcinogenesis
Internal medicine
Cohort
medicine
business
Prospective cohort study
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........98b979c3ac3d4364a0c1969894be45b1